monkeypox
viru
mpxv
orthopoxviru
broadhost
rang
capabl
infect
mani
anim
speci
human
mpxv
caus
diseas
similar
close
relat
variola
viru
etiolog
agent
smallpox
rash
week
period
macul
develop
form
papul
vesicl
pustul
preced
day
incub
follow
day
interv
character
prodrom
fever
malais
sever
lymphadenopathi
neck
inguin
axillari
region
virul
strain
mpxv
congo
basin
region
induc
mortal
rate
main
clinic
differ
human
mpx
smallpox
present
lymphadenopathi
former
mpxv
endem
central
west
africa
increas
number
human
infect
report
transmiss
mpxv
becam
acut
obviou
outbreak
occur
unit
state
mpxv
transmit
human
prairi
dog
global
vaccin
campaign
erad
smallpox
util
vaccin
also
efficaci
mpxv
success
anim
reservoir
variola
inde
prior
erad
smallpox
exist
mpxv
unknown
like
mani
case
human
mpx
report
smallpox
case
human
mpx
increas
africa
may
due
sever
factor
increas
interact
human
infect
anim
environment
degrad
cessat
routin
vaccin
smallpox
increas
human
suscept
viru
increas
animalhuman
humanhuman
transmiss
viru
adapt
viru
new
host
speci
coexist
close
human
geograph
region
high
mortal
rate
morbid
rate
mpxv
human
make
import
emerg
diseas
studi
date
antivir
fdaapprov
treatment
human
mpx
vaccin
smallpox
demonstr
good
protect
mpxv
anim
model
anecdot
human
howev
first
secondgener
smallpox
vaccin
associ
least
level
morbid
larg
proport
popul
contraind
vaccin
thirdgener
vaccin
mva
shown
safer
nonhuman
primat
requir
administr
complet
protect
ergo
new
efficaci
vaccin
protect
human
mpx
would
use
use
modern
genet
engin
techniqu
possibl
isol
identifi
sequenc
import
gene
pathogen
organ
place
new
viral
vaccin
vector
faith
express
present
immun
system
minim
chanc
revers
virul
vaccin
benefici
properti
live
kill
vaccin
retain
viral
vector
passiv
deliveri
system
rather
activ
stimul
innat
adapt
immun
viral
vector
ident
even
within
class
viru
difficult
predict
current
knowledg
variou
potenti
viral
agent
viru
best
fulfil
vaccinevector
goal
consequ
new
vaccinevector
agent
base
virus
must
explor
bovin
herpesviru
gammaherpesviru
directli
associ
specif
diseas
establish
persist
infect
monocytemacrophag
cell
lineag
natur
host
bovin
contrast
virus
belong
famili
proof
growthtransform
identifi
mani
genom
gene
dispens
potenti
delet
accommod
kb
foreign
dna
characterist
import
exploit
vaccin
vector
isol
rumin
speci
zebu
bo
indicu
american
bison
bison
bison
african
buffalo
synceru
caffer
sheep
sporad
isol
report
lion
cat
experiment
also
shown
infect
goat
guinea
pig
mice
rat
rabbit
vitro
abl
replic
primari
cell
cultur
cell
line
variou
anim
speci
cattl
sheep
goat
swine
cat
dog
rabbit
mink
hors
turkey
ferret
chicken
hamster
rat
mice
monkey
recombin
clone
bacteri
artifici
chromosom
bac
express
immunedomin
antigen
differ
pathogen
shown
success
immun
mice
rat
rabbit
sheep
swine
goat
moreov
herp
simplex
viru
thymidin
kinas
gene
arm
vector
display
enhanc
oncolyt
properti
immunecompet
orthotop
syngen
mous
rat
glioma
model
use
mous
model
evalu
capabl
vector
express
mpxv
antigen
elicit
protect
immun
respons
lethal
mpxv
challeng
capac
vector
elicit
protect
immun
respons
compar
smallpox
vaccin
mva
known
induc
littl
morbid
thu
establish
start
point
vector
applic
toward
mpx
import
human
diseas
african
green
monkey
kidney
vero
atcc
bovin
embryo
kidney
bek
dr
ferrari
istituto
zooprofilattico
sperimental
brescia
itali
bs
bek
express
cre
recombinas
bekcr
human
embryo
kidney
hek
atcc
cell
line
cultur
complet
growth
medium
eagl
minim
essenti
medium
emem
lonza
contain
fetal
bovin
serum
fb
mm
lglutamin
sigma
iuml
penicillin
sigma
streptomycin
sigma
amphotericin
b
sigma
incub
cercopithecu
aethiop
epitheli
kidney
cell
atcc
ccl
grown
dmem
lonza
basel
switzerland
contain
fetal
calf
serum
fc
hyclon
iii
logan
ut
mm
lglutamin
gibco
grand
island
ny
uml
penicillin
gibco
grand
island
ny
streptomycin
gibco
grand
island
ny
orf
amplifi
monkeypox
dna
strain
access
use
primer
pair
list
tabl
sens
primer
contain
nhei
restrict
site
along
kozak
sequenc
preced
atg
better
translat
initi
wherea
antisens
primer
contain
sali
restrict
site
infram
clone
orf
tag
peptid
present
plasmid
vector
human
cytomegaloviru
immedi
earli
gene
cmv
promot
immunoglobulin
kappa
light
chain
leader
sequenc
igk
bluetongu
viru
orf
epitop
bovin
herpesviru
glycoprotein
success
use
tag
clone
bovin
growth
hormon
polyadenyl
site
orf
cut
nheisali
clone
cut
enzym
strategi
allow
substitut
sequenc
orf
gener
gener
cut
bamhi
treat
dna
polymeras
blunt
end
cut
nhei
bp
excis
insert
shuttl
vector
cut
nheismai
replac
gfp
orf
chimer
protein
contain
two
thymidin
kinas
gene
homolog
region
flank
green
fluoresc
protein
gfp
express
cassett
driven
cmv
promot
cut
nheismai
gfp
orf
replac
gener
cmv
promot
substitut
human
elong
factor
alpha
amplifi
pcr
pwpi
plasmid
vector
addgen
plasmid
pwpi
first
linear
pmei
pcr
reaction
carri
coupl
primer
tabl
final
volum
contain
mm
ph
mm
deoxynucleotid
triphosph
mm
mm
kcl
dmso
cycl
consist
denatur
min
primer
anneal
min
elong
sec
pfu
dna
polymeras
bp
amplif
product
check
agaros
gel
visual
ethidium
bromid
stain
tae
buffer
mm
trisacet
mm
edta
construct
obtain
subclon
express
cassett
cut
ndeimlui
bluntedend
dna
polymeras
respect
smai
cut
enzym
purchas
thermo
scientif
confluent
cell
seed
well
plate
cellswel
incub
cell
subconflu
cultur
medium
remov
cell
transfect
use
polyethylenimin
pei
transfect
reagent
polysci
inc
briefli
dna
mix
pei
ratio
dna
pei
dulbecco
modifi
essenti
medium
dmem
high
glucos
percentag
euroclon
without
serum
min
rt
medium
without
serum
ad
transfect
solut
transfer
well
left
cell
h
air
humidifi
incub
transfect
mixtur
replac
fresh
medium
emem
fb
iuml
penicillin
streptomycin
amphotericin
b
incub
h
propag
infect
confluent
monolay
bek
vero
cell
multipl
infect
moi
tissu
cultur
infecti
dose
per
cell
maintain
medium
fb
h
medium
remov
replac
fresh
emem
contain
fb
cytopath
effect
cpe
occur
major
cell
monolay
h
post
infect
viru
prepar
freez
thaw
cell
three
time
pellet
virion
sucros
cushion
describ
previous
viru
pellet
resuspend
cold
emem
without
fb
determin
bek
cell
limit
dilut
plaquepurifi
isol
mpxv
strain
purifi
sucros
cushion
propag
cell
viru
infect
estim
describ
previous
briefli
viru
suspens
serial
dilut
pb
fc
fetal
clone
ii
hyclon
absorb
monolay
hour
overlaid
suspens
carboxyl
methyl
cellulos
dmem
fc
day
viru
plaqu
visual
viru
inactiv
addit
well
crystal
formalin
solut
protein
cell
extract
obtain
confluent
plate
transfect
confluent
flask
bek
cell
vero
cell
infect
ad
cell
extract
buffer
mm
mm
nacl
ph
gel
electrophoresi
use
analyz
cell
extract
contain
total
protein
protein
transfer
nylon
membran
electroblot
membran
incub
bovin
anti
monoclon
antibodi
clone
vrmd
inc
pullman
wa
antibodi
probe
horseradish
peroxidaselabel
antimous
immunoglobulin
antibodi
sigma
visual
enhanc
chemiluminesc
ecl
kit
pierc
recombin
perform
previous
describ
modif
five
hundr
microlit
overnight
cultur
contain
dilut
ml
lb
medium
without
chloramphenicol
sigma
select
mgml
ml
baffl
conic
flask
grown
shake
water
bath
ml
transfer
anoth
baffl
ml
conic
flask
heatshock
exactli
min
shake
water
bath
remain
cultur
left
uninduc
control
min
two
sampl
induc
uninduc
briefli
cool
icewat
bath
slurri
transfer
two
falcon
tube
pellet
use
rpm
eppendorf
centrifug
min
supernat
pour
pellet
resuspend
icecold
gentli
swirl
tube
icewat
bath
slurri
subsequ
ml
icecold
ad
sampl
pellet
step
repeat
supernat
remov
pellet
kept
ice
electropor
gelpurifi
fragment
kb
respect
obtain
cut
claipvuii
thermo
scientif
aliquot
ng
use
electropor
cm
cuvett
kv
electropor
counter
select
step
bacteria
recov
ml
lb
ml
baffl
conic
flask
incub
shake
water
bath
bacteria
serial
dilut
plate
minim
medium
plate
contain
gl
agar
glycerol
dbiotin
mgl
lleucin
deoxygalactos
mgml
chloramphenicol
complement
medium
purchas
sigma
plate
incub
day
sever
select
coloni
pick
streak
mcconkey
agar
indic
plate
difco
bd
bioscienc
contain
gml
chloramphenicol
incub
day
white
coloni
appear
white
coloni
grown
duplic
lb
contain
mgml
kanamycin
sigma
lb
contain
mgml
chloramphenicol
coloni
kanamycin
neg
chloramphenicol
posit
kept
grown
overnight
lb
contain
mgml
chloramphenicol
bac
dna
purifi
analyz
hindiii
restrict
enzym
digest
fragment
target
integr
separ
electrophoresi
overnight
agaros
gel
stain
ethidium
bromid
capillari
transfer
posit
charg
nylon
membran
roch
crosslink
uv
irradi
standard
procedur
hybrid
digoxigeninlabel
probe
confirm
ident
specif
restrict
fragment
bp
amplicon
probe
gener
pcr
primer
senseantisens
senseantisens
senseantisens
list
tabl
previous
describ
origin
detail
protocol
recombin
also
found
recombin
websit
http
recombineeringncifcrfgov
bek
bekcr
cell
maintain
monolay
complet
dmem
growth
medium
fb
mm
lglutamin
iuml
penicillin
mgml
streptomycin
cell
subconflu
split
fresh
cultur
vessel
ie
everi
day
incub
humidifi
atmospher
bac
dna
electropor
dmem
without
serum
equibio
apparatu
v
mf
gap
cuvett
bek
bekcr
cell
confluent
flask
electropor
cell
return
flask
medium
replac
fresh
medium
cell
split
reach
confluenc
day
postelectropor
cell
left
grow
appear
cpe
recombin
virus
propag
infect
confluent
monolay
bek
cell
moi
per
cell
maintain
mem
fb
h
bek
cell
infect
moi
incub
h
infect
cell
wash
serumfre
emem
overlaid
emem
contain
fb
mm
lglutamin
iuml
penicillin
mgml
streptomycin
amphotericin
b
supernat
infect
cultur
harvest
h
amount
infecti
viru
determin
limit
dilut
bek
cell
method
eightweek
old
femal
mice
bred
inhous
hous
filtertop
microisol
cage
fed
commerci
mous
chow
water
ad
libitum
random
mice
hous
anim
biosafeti
level
contain
area
micegroup
anim
husbandri
experiment
procedur
approv
institut
anim
care
use
committe
mice
monitor
everi
day
termin
experi
anim
use
protocol
entitl
pathogenesi
orthopoxvirus
efficaci
test
orthopoxviru
vaccin
antivir
approv
saint
loui
univers
institut
anim
care
use
committe
iacuc
saint
loui
univers
usda
regist
research
facil
regularli
inspect
file
requir
document
includ
annual
report
addit
provis
public
health
servic
polici
human
care
use
laboratori
anim
univers
file
requir
assur
document
offic
laboratori
anim
welfar
olaw
olaw
assur
number
effect
march
march
anim
care
use
program
saint
loui
univers
fulli
accredit
associ
assess
accredit
laboratori
anim
care
intern
aaalaci
continu
accredit
notif
juli
vector
inject
intraperiton
ip
total
volum
dmem
use
vehicl
vaccin
one
vector
inject
compris
l
vector
vehicl
combin
inject
l
vector
includ
total
l
inject
given
primari
vaccin
day
booster
vaccin
day
see
tabl
vector
inject
modifi
vaccinia
ankara
mva
gift
niaidnih
bethesda
md
provid
dose
plaqu
form
unit
pfu
ml
inject
ml
skin
underli
layer
tissu
scapular
region
back
mice
mice
anesthet
g
bodi
weight
ketamin
hcl
mgml
xylazin
mgml
intraperiton
inject
anesthet
mice
laid
dorsal
side
bodi
angl
anterior
end
rais
surfac
plastic
mous
holder
use
ensur
conform
mpxv
dilut
pb
without
requir
concentr
slowli
load
nare
lnare
mice
subsequ
left
situ
minut
return
cage
pair
ttest
tail
use
compar
mean
group
mice
mortal
rate
compar
use
fisher
exact
test
blind
lesion
pictur
measur
qualit
use
score
system
rang
sever
p
valu
consid
statist
signific
among
approxim
gene
compris
monkeypox
viru
genom
gene
encod
antigen
abl
elicit
neutral
antibodi
respons
vaccin
anim
among
antigen
ortholog
select
candid
antigen
deliv
basedvector
orf
amplifi
pcr
cosmid
librari
subclon
frame
tag
peptid
fig
contain
mammalian
express
vector
plasmid
construct
tag
orf
place
transcript
control
promot
fig
wherea
tag
orf
transcript
control
cmv
promot
fig
gener
express
cassett
valid
term
protein
express
transient
transfect
cell
westernimmunoblot
monoclon
antibodi
direct
tag
peptid
tag
antigen
well
express
whole
cell
extract
transient
transfect
cell
fig
also
secret
fig
supernat
transient
transfect
cell
apathogen
strain
clone
bac
use
creat
vector
tk
genom
locu
util
integr
site
express
cassett
tk
genom
region
strongli
conserv
among
isol
ensur
stabil
genom
locu
potenti
recombin
foreign
dna
sequenc
insert
inde
tk
genom
locu
interrupt
insert
foreign
dna
sequenc
differ
size
without
interf
viral
replic
vitro
loss
heterolog
protein
express
express
cassett
first
subclon
shuttl
vector
plasmid
contain
tk
sequenc
gener
target
vector
restrict
enzym
linear
target
vector
use
heatinduc
homolog
recombin
e
coli
contain
fig
gener
select
clone
first
analyz
hindiii
restrict
enzym
digest
southern
blot
fig
heatinduc
recombin
e
coli
repeat
passag
could
establish
alter
bacteri
phenotyp
due
aberr
recombenas
transcript
e
coli
carri
serial
cultur
passag
check
hindiii
restrict
enzym
digest
differ
among
restrict
pattern
variou
passag
detect
fig
thu
ensur
stabil
clone
infecti
viabl
obtain
electropor
dna
bek
bekcr
cell
differ
recombin
virus
reconstitut
electropor
bekcr
result
deplet
bac
plasmid
backbon
contain
gfp
express
cassett
shown
loss
gfp
express
fig
time
necessari
reconstitut
viabl
recombin
differ
among
interest
know
foreign
antigen
encod
express
cassett
integr
viral
genom
could
detriment
effect
viral
replic
therefor
growth
characterist
compar
parent
viru
although
demonstr
slower
replic
kinet
respect
reach
viral
titer
endpoint
fig
wherea
replic
drastic
impair
log
reduct
viral
titer
endpoint
respect
observ
fig
howev
transgen
express
well
detect
whole
cell
extract
infect
cell
fig
glycoprotein
found
express
secret
protein
supernat
infect
cell
fig
test
efficaci
vector
vivo
sought
determin
could
protect
mice
lethal
challeng
mpxv
sever
murin
strain
develop
model
mpxv
studi
util
strain
thirteen
cage
prepar
micecag
tabl
cage
unvaccin
cage
vaccin
vehicl
dmem
without
fb
cage
vaccin
mva
cage
receiv
primari
inject
vaccin
day
vehicl
booster
day
cage
receiv
primari
inject
vaccin
day
booster
inject
vaccin
day
similar
vaccin
regimen
perform
cage
vaccin
cage
vaccin
cage
vaccin
cage
also
vaccin
follow
regimen
howev
mice
receiv
combin
combo
vector
vector
inject
ip
total
volum
ml
appar
measur
weightloss
record
mice
fig
day
mice
cage
challeng
pfumous
mpxv
mortal
rate
shown
fig
expect
mva
vaccin
mice
cage
mvaveh
mvamva
protect
challeng
mice
cage
also
protect
p
although
mice
cage
combocombo
experienc
death
still
protect
mpxv
challeng
p
compar
weightchang
fig
found
mice
cage
mvamva
lose
weight
compar
pb
control
cage
mice
cage
mvaveh
lost
weight
day
post
challeng
also
found
mice
cage
comboveh
combocombo
significantli
reduc
weightloss
day
post
challeng
day
respect
even
though
mice
cage
protect
challeng
protect
weightloss
also
afford
mice
cage
day
post
challeng
data
indic
presenc
requir
protect
mice
challeng
booster
vaccin
requir
also
indic
combin
vector
improv
protect
weightloss
although
could
provid
protect
inferior
provid
vaccin
mva
data
also
indic
although
provid
protect
mortal
provid
protect
weightloss
surviv
mice
see
aim
current
studi
ascertain
potenti
util
bovin
herpesviru
base
vector
safe
potent
largecapac
vaccin
vector
categori
specif
case
studi
demonstr
protect
model
consider
given
also
evalu
vector
casteij
mice
also
establish
murin
model
monkeypox
ultim
studi
could
pave
way
studi
anim
model
prairi
dog
cynomi
ludovicianu
ground
squirrel
spermophilu
tridecemlineatu
nonhuman
primat
review
extens
use
model
human
ultim
human
protect
studi
fact
sinc
mpxv
also
infect
human
caus
clinicalsign
similar
smallpox
classifi
categori
select
agent
primarili
ethic
also
cost
reason
knockout
mice
chosen
vivo
model
progress
gene
deliveri
immunogen
studi
nonhuman
primat
micear
highli
sensit
mpxv
diseas
cours
mpxv
infect
mice
character
weight
loss
death
day
post
similar
observ
wildtyp
mice
infect
mousepoxectromelia
viru
ectv
etiolog
agent
probabl
best
small
anim
model
smallpox
moreov
reveal
antivir
therapi
could
protect
mice
degre
similar
vaccin
dryvax
mva
support
use
mice
reliabl
model
evalu
orthopoxviru
prophylact
therapeut
mice
found
sensit
wide
number
pathogen
due
loss
key
factor
respons
type
interferon
ifn
signal
vector
wild
type
immunocompromis
mice
behav
replic
incompet
viral
vector
show
absenc
pathogen
replic
strongli
impair
vitro
treatment
infect
cell
consid
activ
potenti
pathogen
vector
mice
concern
howev
intra
periton
inocul
mice
show
overt
clinic
sign
detriment
effect
patholog
correl
challeng
mpxv
antigen
select
candid
antigen
deliv
vector
ortholog
vaccinia
viru
vv
antigen
respect
kda
protein
thought
involv
vv
entri
event
kda
myristoyl
surfac
protein
involv
yettobeidentifi
post
viral
attach
prefus
event
wherea
kda
glycoprotein
found
surfac
viru
involv
cell
surfac
glycosaminoglycanmedi
disrupt
viral
outer
membran
shown
abl
elicit
protect
immun
respons
mice
nonhuman
primat
formul
combin
subunit
vaccin
consist
purifi
protein
plasmid
dna
vaccin
recombin
adenoviru
alphaviru
replicon
sinc
purpos
studi
determin
capabl
viral
vector
protect
mice
lethal
mpxv
infect
first
concern
gener
optim
express
cassett
integr
genom
abl
effici
express
antigen
antibodi
avail
protein
short
infram
sequenc
code
tag
peptid
provid
end
orf
allow
express
monitor
western
immunoblot
initi
tag
orf
custom
transcript
control
cmv
promot
howev
orf
effici
express
reason
cmv
promot
express
cassett
substitut
human
promot
induc
express
reason
cmv
promot
work
orf
determin
anoth
interest
observ
presenc
protein
supernat
transfect
cell
despit
absenc
canon
signal
peptid
within
primari
sequenc
protein
deduc
differ
signal
peptid
predict
softwar
http
http
wwwcbsdtudkservicessignalp
http
phobiussbcsus
fact
protein
analysi
secretomep
http
wwwcbsdtudkservicessecretomep
sequenc
base
method
predict
mammalian
secretori
protein
target
nonclass
secretori
pathway
includ
within
group
nonclass
secret
protein
like
fibroblast
growth
factor
interleukin
galectin
consid
viru
without
clear
diseas
associ
exist
potenti
pathogen
biotyp
absolut
exclud
viru
go
exploit
gene
deliveri
vector
bovin
herpesviru
consist
associ
uterin
diseas
postpartum
cattl
infect
often
identifi
concurr
bacteria
caus
uterin
diseas
associ
infect
uterin
diseas
difficult
establish
suggest
may
associ
bacteri
endometr
lead
secret
prostaglandin
stimul
viral
replic
lipopolysaccharid
lp
caus
endometri
tissu
damag
inflamm
reason
put
nonpathogen
strain
isol
cell
milk
fraction
healthi
cow
whose
genom
clone
bacteri
artifici
chromosom
use
integr
tk
locu
prove
stabl
passag
e
coli
recombin
viabl
success
reconstitut
bekcr
cell
character
term
replic
kinet
reduct
replic
observ
attribut
partial
toxic
effect
induc
abund
express
also
observ
transfect
cell
express
cassett
latter
observ
exclud
potenti
detriment
effect
induc
topolog
locat
foreign
dna
genom
despit
replic
characterist
three
recombin
abundantli
express
transgen
infect
cell
vivo
protect
studi
determin
protect
lethal
mpxv
challeng
one
hundr
protect
achiev
vector
administ
twice
prime
follow
booster
although
express
vector
superior
vaccin
mva
measur
weightloss
protect
also
afford
mice
vector
administ
combin
combo
prime
booster
mice
experienc
less
weightloss
mice
vaccin
alon
find
surpris
vector
includ
combo
protect
administ
individu
although
find
protect
weightloss
mice
treat
alon
nevertheless
studi
reveal
protect
afford
even
small
number
mice
use
studi
consid
increas
dose
vector
administ
mice
also
sinc
combin
vector
gave
protect
mortal
morbid
variou
vector
permut
consid
elucid
efficaci
combin
ratio
vector
overt
clinicalsign
observ
follow
vaccin
prime
booster
inject
suggest
low
immunoreact
therefor
possibl
lowlevel
advers
event
nhp
human
although
second
gener
live
vaccin
provid
robust
immun
respons
quit
reactogen
induc
level
morbid
vaccin
furthermor
signific
portion
human
popul
contraind
vaccin
first
secondgener
vaccin
mva
nonrepl
vaccin
demonstr
efficaci
mani
anim
trial
main
drawback
mva
rel
low
immunogen
mean
booster
administr
usual
requir
protect
morbid
mortal
futur
studi
could
reveal
vector
studi
could
use
altern
mva
summari
find
demonstr
base
vector
use
vaccin
protect
lethal
mpxv
challeng
mice
studi
util
mice
howev
strain
demonstr
sensit
mpxv
name
casteeij
strain
futur
studi
consid
evalu
protect
vector
strain
also
work
provid
proofofconcept
vector
potenti
vaccin
categori
agent
futur
ongo
studi
focus
design
vector
express
antigen
categori
pathogen
well
assess
protect
nonhuman
primat
